Reconsidering Prostate Cancer Mortality — The Future of PSA Screening

Authors: H. Gilbert Welch, Peter C. Albertsen - New England Journal of Medicine, NEJM 2020 cited by 181

Since PSA screening and the treatment that may follow result in trading off one cause of death for another, rather than extending life, providers who support such screening should offer patients a better deal by protecting them from overdiagnosis and overtreatment.